More importantly, overexpression of Zrsr1 restored minor intron retention and ameliorated the development of MASH, indicating that dysfunctional minor intron splicing is an emerging pathogenic mechanism that drives MASH progression. The gene discussed is ZRSR2P1; the disease is metabolic dysfunction-associated steatohepatitis.